FREISSMUTH MICHAEL,GLOECKEL CHRISTINA,KOENIG XAVER,KEUERLEBER SIMON
申请号：
PL12704027
公开号：
PL2672957T3
申请日:
2012.02.03
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The present invention provides a composition comprising at least one prostacyclin or prostacyclin analog or a pharmaceutically acceptable salt thereof and at least one phosphodiesterase (PDE) 4 inhibitor and optionally a further PDE inhibitor for use in preventing or treating cystic fibrosis by selectively increasing the cAMP levels in bronchoepithelial cells.
